SCHEMBL22864465

SCHEMBL22864465

Cc1ccc(I)c(F)c1Br

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11114934 0.79 ALDH1A1 (0.33)
SCHEMBL582974 0.77 HPGD (0.34)
SCHEMBL16915208 0.75 ACHE (0.36)
SCHEMBL1507770 0.75
SCHEMBL8979083 0.75
SCHEMBL23099880 0.75 CYP1A2 (0.31)
SCHEMBL30906668 0.75
SCHEMBL11276174 0.75 ALDH1A1 (0.31)
SCHEMBL22289292 0.71 NOTUM (0.39)
SCHEMBL22162367 0.71 HTR2A (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114555585-A HPK1 inhibitors and uses thereof 上海齐鲁锐格医药研发有限公司 2022-05-27 CN disclosed
WO-2021000935-A1 HPK1 INHIBITORS AND USES THEREOF QILU REGOR THERAPEUTICS INC. (CN) 2021-01-07 WO disclosed